Photo from George Yaghmour/LinkedIn
Apr 12, 2024, 11:09
George Yaghmour: Excited to share our recent findings on FLT3 inhibitor maintenance therapy post-HSCT
George Yaghmour, Associate Director of USC Norris Blood and Marrow Transplant Program at University of Southern California, shared on LinkedIn:
“Excited to share our recent findings on FLT3 inhibitor maintenance therapy post-HSCT, showing promising outcomes. Our study highlights the importance of timing and choice of inhibitors in improving patient survival.
The study, limited by its single-center focus and observational nature, leaves room for considerations such as clinician decisions, inhibitor choice, and donor factors affecting outcomes.”
Visit the article website.
Source: George Yaghmour/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 14:56
Nov 21, 2024, 14:41
Nov 21, 2024, 13:55
Nov 21, 2024, 13:46
Nov 21, 2024, 13:25
Nov 21, 2024, 12:57
Nov 21, 2024, 12:54